197 related articles for article (PubMed ID: 34447677)
1. Serum Resistin Levels in Adult Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
Han D; Chen J; Liu S; Zhang Z; Zhao Z; Jin W; Xin Y
J Clin Transl Hepatol; 2021 Aug; 9(4):484-493. PubMed ID: 34447677
[TBL] [Abstract][Full Text] [Related]
2. Systematic Review and Meta-analysis of Circulating Fetuin-A Levels in Nonalcoholic Fatty Liver Disease.
Liu S; Xiao J; Zhao Z; Wang M; Wang Y; Xin Y
J Clin Transl Hepatol; 2021 Feb; 9(1):3-14. PubMed ID: 33604250
[TBL] [Abstract][Full Text] [Related]
3. Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis.
Du SX; Lu LL; Geng N; Victor DW; Chen LZ; Wang C; Yue HY; Xin YN; Xuan SY; Jin WW
Lipids Health Dis; 2017 Dec; 16(1):228. PubMed ID: 29197393
[TBL] [Abstract][Full Text] [Related]
4. Circulating chemerin levels in metabolic-associated fatty liver disease: a systematic review and meta-analysis.
Ren Q; Wang H; Zeng Y; Fang X; Wang M; Li D; Huang W; Xu Y
Lipids Health Dis; 2022 Mar; 21(1):27. PubMed ID: 35236351
[TBL] [Abstract][Full Text] [Related]
5. Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Polyzos SA; Toulis KA; Goulis DG; Zavos C; Kountouras J
Metabolism; 2011 Mar; 60(3):313-26. PubMed ID: 21040935
[TBL] [Abstract][Full Text] [Related]
6. Serum Resistin Level and Its Receptor Gene Expression in Liver Biopsy as Predictors for the Severity of Nonalcoholic Fatty Liver Disease.
Hegazy M; Abo-Elfadl S; Mostafa A; Ibrahim M; Rashed L; Salman A
Euroasian J Hepatogastroenterol; 2014; 4(2):59-62. PubMed ID: 29699348
[TBL] [Abstract][Full Text] [Related]
7. Blood Endotoxin Levels as Biomarker of Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
Soppert J; Brandt EF; Heussen NM; Barzakova E; Blank LM; Kuepfer L; Hornef MW; Trebicka J; Jankowski J; Berres ML; Noels H
Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2746-2758. PubMed ID: 36470528
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum level of resistin is associated with risk for gestational diabetes mellitus: A meta-analysis.
Hu SM; Chen MS; Tan HZ
World J Clin Cases; 2019 Mar; 7(5):585-599. PubMed ID: 30863758
[TBL] [Abstract][Full Text] [Related]
9. Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Zhou Z; Chen H; Ju H; Sun M
Lipids Health Dis; 2017 Sep; 16(1):180. PubMed ID: 28931435
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor necrosis factor-α levels in non-alcoholic fatty liver disease: A systematic review and a meta-analysis.
Potoupni V; Georgiadou M; Chatzigriva E; Polychronidou G; Markou E; Zapantis Gakis C; Filimidou I; Karagianni M; Anastasilakis D; Evripidou K; Ftergioti A; Togkaridou M; Tsaftaridis N; Apostolopoulos A; Polyzos SA
J Gastroenterol Hepatol; 2021 Nov; 36(11):3002-3014. PubMed ID: 34289181
[TBL] [Abstract][Full Text] [Related]
11. Circulating leptin in patients with nonalcoholic fatty liver disease-related liver fibrosis: a systematic review and a meta-analysis.
Makri ES; Evripidou K; Polyzos SA
J Gastroenterol Hepatol; 2024 May; 39(5):806-817. PubMed ID: 38238084
[TBL] [Abstract][Full Text] [Related]
12. Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.
Singh S; Allen AM; Wang Z; Prokop LJ; Murad MH; Loomba R
Clin Gastroenterol Hepatol; 2015 Apr; 13(4):643-54.e1-9; quiz e39-40. PubMed ID: 24768810
[TBL] [Abstract][Full Text] [Related]
13. Circulating resistin is elevated in patients with non-alcoholic fatty liver disease and is associated with steatosis, portal inflammation, insulin resistance and nonalcoholic steatohepatitis scores.
Senateş E; Colak Y; Yeşil A; Coşkunpinar E; Sahin O; Kahraman OT; Erkalma Şenateş B; Tuncer I
Minerva Med; 2012 Oct; 103(5):369-76. PubMed ID: 23042372
[TBL] [Abstract][Full Text] [Related]
14. Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Polymerou V; Papadimitriou KG; Zavos C; Katsinelos P
Ann Hepatol; 2016; 15(5):705-14. PubMed ID: 27493109
[TBL] [Abstract][Full Text] [Related]
15. Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease.
Aida Y; Abe H; Tomita Y; Nagano T; Seki N; Sugita T; Itagaki M; Ishiguro H; Sutoh S; Aizawa Y
Int J Clin Exp Med; 2014; 7(11):4191-8. PubMed ID: 25550930
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor-1 and non-alcoholic fatty liver disease: a systemic review and meta-analysis.
Yao Y; Miao X; Zhu D; Li D; Zhang Y; Song C; Liu K
Endocrine; 2019 Aug; 65(2):227-237. PubMed ID: 31243652
[TBL] [Abstract][Full Text] [Related]
17. Association Between Fibrosis Stage and Outcomes of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.
Taylor RS; Taylor RJ; Bayliss S; Hagström H; Nasr P; Schattenberg JM; Ishigami M; Toyoda H; Wai-Sun Wong V; Peleg N; Shlomai A; Sebastiani G; Seko Y; Bhala N; Younossi ZM; Anstee QM; McPherson S; Newsome PN
Gastroenterology; 2020 May; 158(6):1611-1625.e12. PubMed ID: 32027911
[TBL] [Abstract][Full Text] [Related]
18. Association between resistin +299A/A genotype and nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus.
Zhang LY; Jin YJ; Jin QS; Lin LY; Zhang DD; Kong LL
Gene; 2013 Oct; 529(2):340-4. PubMed ID: 23954219
[TBL] [Abstract][Full Text] [Related]
19. Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease.
Ozturk O; Colak Y; Senates E; Yilmaz Y; Ulasoglu C; Doganay L; Ozkanli S; Oltulu YM; Coskunpinar E; Tuncer I
World J Gastroenterol; 2015 Jul; 21(26):8096-102. PubMed ID: 26185381
[TBL] [Abstract][Full Text] [Related]
20. Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.
Polyzos SA; Aronis KN; Kountouras J; Raptis DD; Vasiloglou MF; Mantzoros CS
Diabetologia; 2016 Jan; 59(1):30-43. PubMed ID: 26407715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
